These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10772121

  • 1. Clinical evaluation of 61 patients with pulmonary aspergilloma.
    Kawamura S, Maesaki S, Tomono K, Tashiro T, Kohno S.
    Intern Med; 2000 Mar; 39(3):209-12. PubMed ID: 10772121
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of pulmonary aspergilloma with itraconazole.
    Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW.
    Thorax; 1991 Nov; 46(11):839-41. PubMed ID: 1663275
    [Abstract] [Full Text] [Related]

  • 6. [Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group].
    Tsubura E.
    Kekkaku; 1997 Oct; 72(10):557-64. PubMed ID: 9386354
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R, Loebenberg D, Rinaldi MG, Graybill JR.
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aspergilloma: comparison of treatment methods and prognoses.
    Mori T, Ebe T, Isonuma H, Matsumura M, Takahashi M, Kohara T, Miyazaki T, Igari J, Oguri T.
    J Infect Chemother; 2000 Dec; 6(4):233-9. PubMed ID: 11810572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR.
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.
    Gallien S, Fournier S, Porcher R, Bottero J, Ribaud P, Sulahian A, Socié G, Molina JM.
    Infection; 2008 Dec; 36(6):533-8. PubMed ID: 19011743
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
    Kawana A.
    Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
    Hashimoto M, Honda Y, Fujishima T.
    Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242
    [Abstract] [Full Text] [Related]

  • 19. Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.
    Impens N, De Greve J, De Beule K, Meysman M, De Beuckelaere S, Schandevyl W.
    Eur Respir J; 1990 Jul; 3(7):837-9. PubMed ID: 2175709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.